Amyris Inc. (NASDAQ:AMRS) trading with an addition of $0.45 to $13.06 on Thursday, an upside of 3.57 percent. An average of 3,115,498 shares of common stock have been traded in the last five days. There was a gain of $0.92 in the past week, and it reached a new high 28 times over the past 12 months. The last 20 days have seen an average of 3,026,319 shares traded, while the 50-day average volume stands at 3,154,482.
AMRS stock has decreased by -4.03% in the last month. The company shares reached their 1-month lowest point of $11.73 on 10/06/21. With the stock rallying to its 52-week high on 03/15/21, shares of the company touched a low of $1.88 and a high of $23.42 in 52 weeks. It has reached a new high 15 times so far this year and achieved 104.21% or $6.91 in price. In spite of this, the price is down -44.24% from the 52-week high.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
42 days have passed since Amyris Inc. (AMRS) last reported insider trading activity. ALVAREZ EDUARDO, who is CHIEF OPERATING OFFICER, most recently acquired $17,605 shares at $14.86 per share on Sep 02. In this transaction, the insider spent $261,610. CHIEF LEGAL OFFICER- SECRETARY, KELSEY NICOLE, disposed of 3,483 shares at a price of $14.86 on Sep 02. The insider now owns more than $51,757 worth of shares. Prior to that, CHIEF FINANCIAL OFFICER Kieftenbeld Hermanus went on to Sale 24,380 shares at $14.86 each on Sep 02. An amount of $362,287 was transacted.
Amyris Inc. (AMRS) has a trailing price-to-earnings (P/E) ratio of 17.00 for the broader industry and 13.88 for the sector. The stock’s beta is 1.45. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 11.33.
The quick ratio of Amyris Inc. for the three months ended September 29 was 3.10, and the current ratio was 3.70, indicating that the company is able to meet its debt obligations. On the profitability front, the trailing 12-month gross margin is 69.10% against a 5-year average of 41.7%. Amyris Inc.’s EBITDA margin for the year ending September 29 is -64.28%. Its gross profit as reported stood at $85.33 million compared to revenue of $173.14 million.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Amyris Inc.’s return on assets was -155.60%, compared to -156.8% over the last five years.
For the three-month period that ended September 29, Amyris Inc. had $13.84 million in total debt. In the quarter under review, the net income was down than the previous quarter. The company posted a net income of $15.37 million in the quarter, while revenues of -$289.15 million were grew 777.03%. The analyst consensus anticipated Amyris Inc.’s latest quarter earnings to come in at -$0.55 per share, but it turned out to be -$1.14, a -107.30% surprise. For the quarter, EBITDA amounted to -$50.95 million. Shareholders own equity worth $297.98 million.
From a technical analysis perspective, let’s take a brief look at Amyris Inc. (AMRS) price momentum. RSI 9-day as of the close on 13 October was 53.46%, suggesting the stock is Neutral, with historical volatility in this time frame at 59.11%.
As of today, AMRS’s price is $12.39 +7.56% or $0.92 from its 5-day moving average. AMRS is currently trading -3.68% lower than its 20-day SMA and -2.24% lower than its 100-day SMA. However, the stock’s current price level is -7.49% below the SMA50 and +134.59% above the SMA200.
The stochastic %K and %D were 28.71% and 19.28%, respectively, and the average true range (ATR) was 0.68. With the 14-day stochastic at 42.43% and the average true range at 0.73, the RSI (14) stands at 49.39%. The stock has reached 0.26 on the 9-day MACD Oscillator while the 14-day reading was at -0.28.
HSBC Securities launched coverage on Amyris Inc. (NASDAQ: AMRS) in its analyst report released on June 01, 2021. The firm assigned the stock a a Buy rating.The consensus rating for Amyris Inc. (AMRS) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell AMRS, while 0 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 6 others rate it as a “buy”.
What is AMRS’s price target for the next 12 months?
Analysts predict a range of price targets between $19.00 and $30.00, with a median target of $21.00. Taking a look at these predictions, the average price target given by analysts for Amyris Inc. (AMRS) stock is $22.83.